CAR T Post Hematopoietic Cell Transplant
A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 32 patients (estimated)
- Sponsors
- Memorial Sloan-Kettering Cancer Center
- Tags
- CAR T Cell, B-Cell Maturation Antigen (BCMA), Post-Allogeneic Stem Cell Transplant, Post-Autologous Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- 15 hours ago
- SparkCures ID
- 1292
- NCT Identifier
- NCT05393804
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.